Huntington National Bank Krystal Biotech, Inc. Transaction History
Huntington National Bank
- $12.3 Billion
- Q1 2024
A detailed history of Huntington National Bank transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Huntington National Bank holds 243 shares of KRYS stock, worth $44,624. This represents 0.0% of its overall portfolio holdings.
Number of Shares
243
Previous 9
2600.0%
Holding current value
$44,624
Previous $1,000
4200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding KRYS
# of Institutions
262Shares Held
21.5MCall Options Held
462KPut Options Held
723K-
Avoro Capital Advisors LLC New York, NY2.56MShares$469 Million5.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$447 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.81MShares$332 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA1.51MShares$277 Million10.58% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$182 Million9.23% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.71B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...